Navigation Links
GeoVax Labs Reports 2012 First Quarter Financial Results
Date:5/15/2012

icate superior protection when compared to similar viral challenge studies for competitive vaccine designs currently in human clinical trials. We are therefore very excited about the potential for our vaccine."

Dr. McNally continued, "On the financial side, we continue to benefit from NIH/HVTN support of our human clinical trials and we are seeking additional government support to fund our internal research and development activities to expand the use of our technology against strains (clades) of the HIV virus affecting other areas of the globe. From December 2011 to March 2012, we raised a total of $2.7 million in equity capital to bolster our cash reserves."

Comment on Gilead Science's Truvada® Prevention SubmissionDr. McNally also commented on the recent news related to an advisory panel's recommendation that the FDA approve Gilead Science's submission of their anti-viral medication, Truvada, for prevention of HIV. "While any positive step towards the control of this deadly disease is greatly welcomed, we must continue the search for safe, cost-effective measures to prevent HIV transmission. The high cost of oral medications, patient compliance, and risk of medical side effects clearly suggest the best solution still lies with a preventive vaccine. GeoVax's preventive vaccine is considered a leading candidate for the version of the virus prevalent in North and South America, and Europe."

Financial ReviewGeoVax reported a net loss for the three months ended March 31, 2012 of $730,513, or $0.04 per share, based on 16.7 million weighted average shares outstanding. For the three months ended March 31, 2011, the Company reported a loss of $606,282, or $0.04 per share, based on 15.7 million weighted average shares outstanding.

The Company reported revenues of $854,063 for the three months ended March 31, 2012, related to its Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) grant from the National Institutes
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. GeoVax Labs CEO Update Letter to Shareholders
2. GeoVax Labs First Patient Inoculated in Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine
3. GeoVax Phase 2a Clinical Trial Completes Enrollment
4. GeoVax $3.6 Million Award Increased to $4.4 Million by U.S. Government
5. GeoVax Labs, Inc. Announces Second Quarter Financial Results
6. GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress
7. GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases
8. GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine
9. David A. Dodd Appointed Chairman of the Board of GeoVax Labs
10. GeoVax Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial
11. GeoVax Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ALISO VIEJO, Calif. , June 30, 2015 ... from the PRISM II study showing that treatment ... statistically significant reduction in symptoms of pseudobulbar affect ... or stroke. PBA is a distressing condition characterized ... crying resulting from certain neurologic diseases or brain ...
(Date:6/30/2015)... – Small Cap IR issues report. Recently, Arrayit Corporation ... blood card technology to Vivos, Global Genome Vault, the ... an impervious, impenetrable and permanent DNA storage vault, able ... Earth, a safe and secure nuclear blast-proof, underground shelter ... rapid collection, separation, drying and storage of human genomic ...
(Date:6/30/2015)... 2015  Egalet Corporation (Nasdaq: EGLT ... company focused on developing, manufacturing and marketing ... from a Category 3 human abuse liability ... oral oxycodone product candidate in late-stage clinical ... enough to require daily, around-the-clock opioid treatment ...
Breaking Medicine Technology:Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 2Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 4Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 5Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 6Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 7Small Cap IR - Empowering the Age of Genetic Enlightenment 2Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 2Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 3Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 4Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 5
... Technologies, Inc. (NYSE Amex: PTN ), ... for the treatment of diseases with significant unmet ... Dr. Carl Spana, President and Chief Executive Officer ... Eighth Annual Equity Conference.  The presentation is scheduled ...
... YORK, Jan. 16, 2012 Reportlinker.com announces ... available in its catalogue: , ... http://www.reportlinker.com/p0760637/Pharmaceutical-MA-in-the-Asia-Pacific-Region.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical ... continues in major developed markets, prompted by ...
Cached Medicine Technology:Palatin Technologies to Present at BOCEMb, Noble Financial Capital Markets' Eighth Annual Equity Conference 2Pharmaceutical M&A in the Asia Pacific Region 2Pharmaceutical M&A in the Asia Pacific Region 3Pharmaceutical M&A in the Asia Pacific Region 4
(Date:6/30/2015)... CA (PRWEB) , ... June 30, 2015 , ... ... Medicare rating in a new video, “Grand Terrace Health Care Center.” Each year, ... accountable and help patients find the best facility for their needs. Grand Terrace ...
(Date:6/30/2015)... ... June 30, 2015 , ... According to a June 15th ... grant to study how sensory stimuli can be used to “decrease children’s anxiety and ... for children with autism, will compare patient experience in a “typical dental environment” with ...
(Date:6/30/2015)... ... , ... Family and professional dementia caregivers are invited to ... 2015 at the Hyatt Regency Denver Tech Center from 7:30 am-4:30 pm. The ... the wife and daughter of singer Glen Campbell, who will discuss their experiences ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... community. , Eleven physicians from Allied’s Fullerton division volunteered to help provide free ... Super Surgery Saturday, March 21, at St. Jude Medical Center. , The ...
(Date:6/30/2015)... ... June 30, 2015 , ... America’s oldest cancer center and ... cancer prevention, screening and care for the people of Nigeria. Roswell Park Cancer ... see Roswell Park faculty providing clinical consultations to assist LCC oncologists, who will ...
Breaking Medicine News(10 mins):Health News:Grand Terrace Health Care Center Announces Five-Star Rating in YouTube Video 2Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 2Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 3Health News:Family of Singer Glen Campbell to Discuss Living with Dementia at the Alzheimer's Association of Colorado's 26th Annual Education Symposium 2Health News:Allied Anesthesia Physicians Volunteer to Help Orange County’s Uninsured During Annual Super Surgery Saturday 2Health News:Allied Anesthesia Physicians Volunteer to Help Orange County’s Uninsured During Annual Super Surgery Saturday 3Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 2Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 3Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 4Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 5
... ... announced it acquired key technology assets from Regenerative Medicine Assets Limited (formerly Intercytex Group ... of its chief competitors, ARI has further solidified its position as the leading research ... ...
... Rather than chocolate, Seattle BioMed,s ... ... are fleeting. But the gift of hope can endure. This Mother’s Day, there might be no ... hope to another mother and her child in a place where help is needed most. ...
... For the promotion ... limits and test the Social Media world on a whole other level , ... Florida (PRWEB) March 25, 2010 -- Take a look at ... Inc ., and previously V.P. of HR at IBM and CEO of Bank of America. ...
... Waltham, MAWith overdoses and deaths involving the use of ... of Justice (DOJ) has selected the Heller School for ... a new initiative to reduce diversion and abuse of ... Funded through a training and technical assistance grant from ...
... for diabetes should be screened, researcher says , THURSDAY, ... and undiagnosed diabetes, millions may have chronic kidney disease ... In the study, researchers looked at a nationally representative ... Health and Nutrition Examination Survey and found that 42 ...
... finds , THURSDAY, March 25 (HealthDay News) -- More than ... said that they drank alcohol in the past month, according ... The analysis of 2006-2008 data from the National Survey on ... rates were as high as 40 percent in some states, ...
Cached Medicine News:Health News:ARI Purchases Intercytex Assets 2Health News:ARI Purchases Intercytex Assets 3Health News:Seattle BioMed Offers the Gift of Hope for Mother's Day 2Health News:Seattle BioMed Offers the Gift of Hope for Mother's Day 3Health News:Seattle BioMed Offers the Gift of Hope for Mother's Day 4Health News:Business Book Author is Breaking All the Rules and Utilizing Social Media in a Way that Has Never Been Done Before 2Health News:Business Book Author is Breaking All the Rules and Utilizing Social Media in a Way that Has Never Been Done Before 3Health News:Business Book Author is Breaking All the Rules and Utilizing Social Media in a Way that Has Never Been Done Before 4Health News:A prescription for excellence 2Health News:Many Americans Unaware They Have Chronic Kidney Disease 2Health News:Underage Drinking Soars in U.S. 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: